Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $24.4000 (1.67%) ($24.1700 - $24.5600) on Mon. Aug. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.29% (three month average) | RSI | 66 | Latest Price | $24.4000(1.67%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.4% a day on average for past five trading days. | Weekly Trend | ATRA advances 4.6% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) IBB(51%) ARKG(50%) IWO(47%) ARKK(45%) | Factors Impacting ATRA price | ATRA will decline at least -1.645% in a week (0% probabilities). VIXM(-16%) TLT(-13%) UUP(-9%) UNG(-3%) IPO(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.645% (StdDev 3.29%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
5 Day Moving Average | $23.84(2.35%) | 10 Day Moving Average | $23.07(5.77%) | 20 Day Moving Average | $22.72(7.39%) | To recent high | 0% | To recent low | 61.2% | Market Cap | $1.813b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |